BLA
AGN

Balter Liquid Alternatives’s Allergan plc AGN Stock Holding History

Balter Liquid Alternatives’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-2,778
Closed -$371K – 261
2018
Q4 		$371K Buy
+2,778
New +$455K 0.26% 122
2017
Q2 		– Sell
-1,965
Closed -$469K – 171
2017
Q1 		$469K Sell
1,965
-1,119
-36% -$261K 0.67% 49
2016
Q4 		$648K Sell
3,084
-1,471
-32% -$305K 1.48% 23
2016
Q3 		$1.05M Buy
4,555
+150
+3% +$36.7K 2.63% 14
2016
Q2 		$1.02M Buy
+4,405
New +$1.02M 2.39% 16

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Balter Liquid Alternatives's AGN Position: Q1 2019 in Review

Balter Liquid Alternatives sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 2,778 shares — an estimated $371K sold.

Balter Liquid Alternatives first reported a position in AGN in Q2 2016 and held it in 5 quarters. The position peaked at $1.05M in Q3 2016. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Balter Liquid Alternatives reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Balter Liquid Alternatives sold 2,778 Allergan plc shares in Q1 2019, an estimated $371K.
  • Balter Liquid Alternatives first reported a position in Allergan plc in Q2 2016 and held it in 5 quarters.
  • Balter Liquid Alternatives's Allergan plc position peaked at $1.05M in Q3 2016.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Balter Liquid Alternatives's 13F filing for Q1 2019, filed 13 May 2019.